Gorevic Jason N's Form 4 filing
Teladoc Health, Inc. (TDOC) · filed Mar 5, 2024
- Accession no.
- 0001477449-24-000044
- Filed
- Mar 5, 2024
- Trade date
- Mar 1-4, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 7 non-derivative transactions and 7 derivative transactions. Open-market sales total $780.5K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gorevic Jason NCIK 0001208500 | Director, Officer (CHIEF EXECUTIVE OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2024 | Common Stock | MOption exerciseAcquired | +21,130 | –F1 | – | 622,864 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseAcquired | +2,915 | –F1 | – | 625,779 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseAcquired | +5,782 | –F1 | – | 631,561 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseAcquired | +5,615 | –F2 | – | 637,176 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseAcquired | +62,004 | –F2 | – | 699,180 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseAcquired | +7,648 | –F2 | – | 706,828 | Direct | |
| Mar 4, 2024 | Common Stock | SSaleDisposed | −53,755 | $14.52 | −$780,522.6 | 653,073 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2024 | Common Stock | AGrant or awardAcquired | +63,393 | $0.00 | $0 | 63,393 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseDisposed | −21,130 | $0.00 | $0 | 42,263 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseDisposed | −2,915 | $0.00 | $0 | 0 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseDisposed | −5,782 | $0.00 | $0 | 0 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseDisposed | −5,615 | $0.00 | $0 | 22,460 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseDisposed | −62,004 | $0.00 | $0 | 124,008 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseDisposed | −7,648 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
Referenced by the price of 3 transactions in Table I.
- F2
Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
Referenced by the price of 3 transactions in Table I.